LGN

Legence Corp.

Industrials · Engineering & Construction · NMS
$83.69
Data: 2026-05-15
✓ ETHICAL PASS

WEAK MOAT
HIGH
Data Confidence: 85.7%
Convergence Score
Score pending — view screener
Market Regime
Analysis pending
Today's Read
Daily framework analysis for Legence Corp.
Full Daily Analysis

Key Metrics

How this company measures up on the fundamentals that matter

Market Cap
$13.8B
Total market value of the company
52.63
Based on estimated future earnings — lower means cheaper
Rev Growth
+105.1%
Year-over-year revenue change
Profit Margin
-0.7%
How much profit the company keeps from each dollar of revenue
-7.2%
Return on equity — how efficiently it uses shareholder money
Analyst Target
$88.42
+6% from current price — median analyst estimate
Recommendation
STRONG_BUY
Consensus view from 17 analysts covering this stock

About Legence Corp.

Legence Corp. provides engineering, installation, and maintenance services for mission-critical systems in buildings in the United States. The company operates through two segments, Engineering & Consulting, and Installation & Maintenance. The Engineering & Consulting segment designs HVAC and other MEP systems for buildings, develops strategies to help reduce energy usage and make buildings more sustainable and provides program and project management services for client's installation and retrofit projects. This segment also offers engineering & design and program and project management services. The Installation & Maintenance segment fabricates and installs HVAC systems, process piping and other MEP systems in new and existing industrial, commercial and institutional buildings and provides ongoing preventative and corrective maintenance services, emergency repair, and break-fix services, as well as facility energy analysis, automation, optimization, and system certification and testing. It serves data centers, technology, life sciences, healthcare, education, mixed-use, state and local government, and other markets. The company was founded in 1914 and is based in San Jose, California.

https://www.wearelegence.com

Country: United States Employees: 7,000 Industry: Engineering & Construction

Ethical Screening

Five compliance checks based on AAOIFI standards — all must pass for ethical clearance

Business Activity
PASS
Core business does not involve prohibited activities
Debt Ratio
8.1% PASS
Debt must be below 33% of total assets
Cash Ratio
1.7% PASS
Interest-bearing cash below 33% of assets
Receivables
0.0% PASS
Receivables below 49% of assets
Revenue Purity
0.0% PASS
Non-compliant revenue below 5% — any excess requires purification

Valuation

$47.96
What our model estimates this business is worth per share
-74.5%
Trading above fair value — no margin of safety
Rating
OVERVALUED
Overall assessment combining ethics, valuation, and quality
84.5th
Ranks in the top 16% of our 13,571 screened universe
Ethical Score
96.3
Valuation Score
16.5
Quality Score
33.8
Combined
56.0

Trading at $84, 75% above fair value of $48. Passes all ethical screens. Ranks better than 55% of screened stocks.

Quantitative Intelligence

Statistical analysis of price behaviour, risk, and market regime — independent of fundamental data

MARKUP
Price trending up with increasing momentum
2.447
Excellent risk-adjusted returns
0.1975
Suggested allocation is meaningful — the edge justifies a position
16.270
Returns exceed worst-case losses — strong risk profile
Annual Return
348.2%
Historical annualised return based on price data
-21.4%
Largest peak-to-trough decline — the worst it has been
SIDEWAYS
Price consolidating — no clear directional bias
Days in State
1
How long the current regime has persisted — longer means more stable

Market Data

Trading characteristics and market positioning

N/A
52W High
$107.24
22% below the year high
52W Low
$26.96
210% above the year low
Avg Volume
1,628,620
Average daily shares traded — higher means easier to buy and sell
1.5
Days it would take all short sellers to cover — higher means more crowded
Short % Float
6.2%
Moderate short interest
0.0%
Annual dividend as a percentage of the share price
$-0.57
Earnings per share over the last 12 months

Financial Health

Balance sheet strength and cash generation — the foundation of long-term value

1.24
Meaningful debt load — monitor closely
1.30
Adequate but worth monitoring
Quick Ratio
1.26
Like current ratio but excludes inventory — stricter test
Gross Margin
19.8%
Revenue left after cost of goods — higher means pricing power
Operating Margin
3.2%
Profit from core operations before interest and tax
$289M
Positive — the business generates more cash than it spends
Revenue (TTM)
$3.1B
Total revenue over the last 12 months
Net Income
$4M
Profitable — the bottom line is positive

Analyst Coverage

Analysts
17
Target High
$120.00
Target Median
$88.42
Target Low
$45.00

Recent Insider Activity

SEC Form 4 filings — what company insiders are buying and selling

Date Insider Title Type Shares Value
2026-03-16 BUTZ STEPHEN M Chief Financial Officer 9,762
2026-03-16 SEKI BRYCE TADAHIRO General Counsel 4,393
2026-03-16 SPRAU JEFFREY Chief Executive Officer 34,167
2026-03-16 BARNES GREGORY Officer 4,393
2026-03-16 LE BRIS PHILIPPE Officer 1,952
2026-03-16 HANSEN STEPHEN DALE Chief Operating Officer 8,298
2026-03-16 SCHWARTZ JUSTIN Officer 3,905
2026-01-08 BLACKSTONE EMA III LLC Beneficial Owner of more than 10% of a Class of Security 1,260,326 $56,714,670
2026-01-08 BLACKSTONE EMA III LLC Beneficial Owner of more than 10% of a Class of Security 780,121
2025-12-16 BLACKSTONE EMA III LLC Beneficial Owner of more than 10% of a Class of Security 8,402,178 $378,098,010
Source: SEC Form 4 filings via public data. View all insider activity at
Insider Intelligence

Latest Analysis — LGN

Timestamped intelligence from our daily research pipeline

3 Jul 2026
17:13 UTC
Uncategorized
LGN — Deep Ticker Analysis | Framework Read 3 July 2026

Legence Corp (LGN) Regime Case Study | Titan Protect LGN MARKUP Ethical Score: 96.3 Legence Corp: Building Efficiency Meets Markup Phase How energy efficiency mandates and infrastructure spending are powering...

3 Jul 2026
08:56 UTC
Uncategorized
LGND — Deep Ticker Analysis | Framework Read 3 July 2026

Ligand Pharmaceuticals (LGND) — Markup at $255.54 with 70.0 Ethical Score body { background: #0a0e14; color: #e0e0e0; font-family: 'Segoe UI', Arial, sans-serif; margin: 0; padding: 0; line-height: 1.7; } .container...

3 Jul 2026
08:40 UTC
Uncategorized
LGND — Deep Ticker Analysis | Framework Read 3 July 2026

Ligand Pharmaceuticals (LGND) — Markup at $255.54 with 70.0 Ethical Score body { background: #0a0e14; color: #e0e0e0; font-family: 'Segoe UI', Arial, sans-serif; margin: 0; padding: 0; line-height: 1.7; } .container...

3 Jul 2026
05:48 UTC
Uncategorized
LGND — Deep Ticker Analysis | Framework Read 3 July 2026

Ligand Pharmaceuticals (LGND) — Markup at $255.54 with 70.0 Ethical Score body { background: #0a0e14; color: #e0e0e0; font-family: 'Segoe UI', Arial, sans-serif; margin: 0; padding: 0; line-height: 1.7; } .container...

3 Jul 2026
05:45 UTC
Uncategorized
LGND — Deep Ticker Analysis | Framework Read 3 July 2026

Ligand Pharmaceuticals (LGND) — Markup at $255.54 with 70.0 Ethical Score body { background: #0a0e14; color: #e0e0e0; font-family: 'Segoe UI', Arial, sans-serif; margin: 0; padding: 0; line-height: 1.7; } .container...

27 Jun 2026
08:31 UTC
Pre-Asia Brief
Titan 25 Q3 2026: IAMGOLD Leads as Gold Hits $4,100 — All 25 Stocks Pass Ethical Screening

Titan Research Desk  |  Weekly Review  |  27 June 2026 Titan 25 Weekly Review: Q3 Opens With 100% Ethical Compliance and Gold at the Top As Q2 closes and Q3...

30 May 2026
16:41 UTC
Option Watch
Titan 25 Elite

Elite Members Only 29 May 2026 — Monthly Convergence Report Every month, our analytical process screens 5,075 tickers across 17 exchanges through multiple independent lenses. Value. Quality. Ethics. Risk-adjusted momentum....

View all daily analysis →
Want deeper analysis on Legence Corp.?
Our framework analyses LGN daily across 19 analytical perspectives — positioning, macro, sentiment, volatility, options, sector rotation, and more. Members get the read 24 hours before anyone else.
Start Free — Explorer Access Open the Convergence Screener View Our Track Record

Data sourced from public filings and market feeds. Not financial advice. Updated: 2026-05-15

Discover More
Alpha Insights Market Intelligence Titan Watch Ethical Screener Insider Intelligence Track Record Ethical Finance Zakat Calculator Iran Oil Tracker Foundry Indicators Options Calendar Composites Boycott Tracker Convergence Screener Fed Tracker Explore All Is It Halal? Earnings Calendar Dividend Screener Country Guides Glossary Join Free →

Get our weekly market brief free.